{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:47:21Z","timestamp":1740160041933,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"F\u0131rat University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Periampullary cancers have a short overall survival (OS), and many prognostic factors have been studied for this purpose. They usually present with biliary obstruction, which negatively affects the liver, kidney, immune system, and cardiovascular system. This study aimed to investigate the effect of MELD-Na scores on OS in patients undergoing pancreaticoduodenectomy due to periampullary cancer. Patients who underwent pancreaticoduodenectomy due to periampullary cancer between January 2010 and January 2021 were included in the study. After applying the exclusion criteria, 80 of the 124 patients were included in the study. The demographic, laboratory, and pathologic data of the patients were analyzed retrospectively. Univariate analysis showed that MELD-Na score at admission, age-adjusted Charlson Comorbidity Index, adjuvant treatment, portal vein resection, lymphovascular invasion (LVI), T-stage, and tumor location were significantly associated with OS (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.1). In multivariate analysis, MELD-Na score at admission (HR: 1.051, 95% CI [1.004\u20131.101]; <jats:italic>p<\/jats:italic>\u2009=\u20090.033), adjuvant treatment (HR: 4.717, 95% CI [2.371\u20139.383]; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), LVI (HR: 2.473, 95% CI [1.355\u20134.515]; <jats:italic>p<\/jats:italic>\u2009=\u20090.003), and tumor location (HR: 2.380, 95% CI [1.274\u20134.445]; <jats:italic>p<\/jats:italic>\u2009=\u20090.007) were independent risk factors for OS. MELD-Na score, adjuvant treatment, LVI, and tumor location were independent risk factors for the OS of periampullary cancer. The MELD-Na score may be used to predict OS for patients undergoing pancreaticoduodenectomy due to periampullary cancer.<\/jats:p>","DOI":"10.1007\/s13304-024-01856-w","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T02:01:30Z","timestamp":1715047290000},"page":"1819-1825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of MELD-Na score on overall survival of periampullary cancer"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8806-4452","authenticated-orcid":false,"given":"Serkan","family":"Y\u0131lmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7845-5169","authenticated-orcid":false,"given":"Mesut","family":"Yur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"1856_CR1","first-page":"1137","volume-title":"Shackelford\u2019s Surgery of The Al\u0131mentary Tract","author":"KEGJ Poruk","year":"2019","unstructured":"Poruk KEGJ, Wolfgang CL, Cameron JL (2019) Pancreatic and Periampullary Cancer. In: Yeo CJDS, Fleshman JW, Matthews JB, McFadden DW (eds) Shackelford\u2019s Surgery of The Al\u0131mentary Tract, 8th edn. Elsevier, Phladelphia, pp 1137\u20131148","edition":"8"},{"key":"1856_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0002-9610(91)91134-5","volume":"161","author":"JH Peters","year":"1991","unstructured":"Peters JH, Carey LC (1991) Historical review of pancreaticoduodenectomy. Am J Surg 161:219\u2013225","journal-title":"Am J Surg"},{"key":"1856_CR3","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.hpb.2022.01.009","volume":"24","author":"EJM de Jong","year":"2022","unstructured":"de Jong EJM, van der Geest LG, Besselink MG et al (2022) Treatment and overall survival of four types of non-metastatic periampullary cancer: nationwide population-based cohort study. HPB (Oxford) 24:1433\u20131442","journal-title":"HPB (Oxford)"},{"key":"1856_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.616108","volume":"11","author":"T Xia","year":"2021","unstructured":"Xia T, Wu X, Mou Y et al (2021) Clinicopathological prognostic factors and chemotherapeutic outcome for two histopathological types of ampulla of vater adenocarcinoma. Front Oncol 11:616108","journal-title":"Front Oncol"},{"key":"1856_CR5","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1002\/cncr.24503","volume":"115","author":"J Helm","year":"2009","unstructured":"Helm J, Centeno BA, Coppola D et al (2009) Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer. Cancer 115:4080\u20134089","journal-title":"Cancer"},{"issue":"Suppl 1","key":"1856_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/liv.14866","volume":"41","author":"E Mauro","year":"2021","unstructured":"Mauro E, Garcia-Olveira L, Gadano A (2021) End-stage liver disease: management of hepatorenal syndrome. Liver Int 41(Suppl 1):119\u2013127","journal-title":"Liver Int"},{"key":"1856_CR7","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00520-012-1640-3","volume":"21","author":"H Engin","year":"2013","unstructured":"Engin H, Bilir C, Ustundag Y (2013) MELD-sodium score and its prognostic value in malignancy-related ascites of pancreatic and gastric cancer. Support Care Cancer 21:1153\u20131156","journal-title":"Support Care Cancer"},{"key":"1856_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.dld.2008.01.015","volume":"40","author":"TI Huo","year":"2008","unstructured":"Huo TI, Lin HC, Hsia CY et al (2008) The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. Dig Liver Dis 40:882\u2013889","journal-title":"Dig Liver Dis"},{"key":"1856_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.21614\/chirurgia.115.2.185","volume":"115","author":"L Schwarz","year":"2020","unstructured":"Schwarz L, Regimbeau JM, Rebibo L (2020) What are the particularities of pancreatic surgery in the cirrhotic patient? Chirurgia (Bucur) 115:185\u2013190","journal-title":"Chirurgia (Bucur)"},{"key":"1856_CR10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/lt.21222","volume":"13","author":"VW Wong","year":"2007","unstructured":"Wong VW, Chim AM, Wong GL, Sung JJ, Chan HL (2007) Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B. Liver Transpl 13:1228\u20131235","journal-title":"Liver Transpl"},{"key":"1856_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.hbpd.2018.01.008","volume":"17","author":"ET Pavlidis","year":"2018","unstructured":"Pavlidis ET, Pavlidis TE (2018) Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary Pancreat Dis Int 17:17\u201321","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1856_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1995-7645(14)60348-5","volume":"8","author":"XM Sun","year":"2015","unstructured":"Sun XM, Kang P, Tao K (2015) Causes of immune dysfunction in hyperbilirubinemia model rats. Asian Pac J Trop Med 8:382\u2013385","journal-title":"Asian Pac J Trop Med"},{"key":"1856_CR13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1189\/jlb.0211070","volume":"90","author":"NM Khan","year":"2011","unstructured":"Khan NM, Poduval TB (2011) Immunomodulatory and immunotoxic effects of bilirubin: molecular mechanisms. J Leukoc Biol 90:997\u20131015","journal-title":"J Leukoc Biol"},{"key":"1856_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1752-8062.2011.00272.x","volume":"4","author":"S Khurana","year":"2011","unstructured":"Khurana S, Raufman JP, Pallone TL (2011) Bile acids regulate cardiovascular function. Clin Transl Sci 4:210\u2013218","journal-title":"Clin Transl Sci"},{"key":"1856_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40487-020-00112-6","volume":"8","author":"R Berardi","year":"2020","unstructured":"Berardi R, Mocchegiani F, Rinaldi S et al (2020) Hyponatremia is a predictor of clinical outcome for resected biliary tract cancers: a retrospective single-center study. Oncol Ther 8:115\u2013124","journal-title":"Oncol Ther"},{"key":"1856_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1046\/j.1365-2168.1998.00661.x","volume":"85","author":"F Martinez-Rodenas","year":"1998","unstructured":"Martinez-Rodenas F, Pereira JA, Jimenez W, Gubern JM, Sitges-Serra A (1998) Circulating bile is the main factor responsible for atrial natriuretic peptide release in experimental obstructive jaundice. Br J Surg 85:480\u2013484","journal-title":"Br J Surg"},{"key":"1856_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0163-7258(93)90028-C","volume":"58","author":"AL Gerbes","year":"1993","unstructured":"Gerbes AL (1993) The role of atrial natriuretic peptide (ANP) in chronic liver disease. Pharmacol Ther 58:381\u2013390","journal-title":"Pharmacol Ther"},{"key":"1856_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"1856_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J, Patierno C (2022) Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom 91:8\u201335","journal-title":"Psychother Psychosom"},{"key":"1856_CR20","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.4103\/jcrt.JCRT_440_18","volume":"16","author":"T Aoyama","year":"2020","unstructured":"Aoyama T, Yamamoto N, Kamiya M et al (2020) The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy. J Cancer Res Ther 16:S116\u2013S121","journal-title":"J Cancer Res Ther"},{"key":"1856_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00535-022-01853-z","volume":"57","author":"Y Takada","year":"2022","unstructured":"Takada Y, Kawashima H, Ohno E et al (2022) The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors. J Gastroenterol 57:199\u2013207","journal-title":"J Gastroenterol"},{"key":"1856_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/MPA.0000000000000112","volume":"43","author":"PE Robert","year":"2014","unstructured":"Robert PE, Leux C, Ouaissi M et al (2014) Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study. Pancreas 43:692\u2013697","journal-title":"Pancreas"},{"key":"1856_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00268-021-06346-3","volume":"46","author":"Y Shimizu","year":"2022","unstructured":"Shimizu Y, Ashida R, Sugiura T et al (2022) Prognostic impact of indicators of systemic inflammation and the nutritional status of patients with resected carcinoma of the ampulla of vater: a single-center retrospective study. World J Surg 46:246\u2013258","journal-title":"World J Surg"},{"key":"1856_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.950335","volume":"12","author":"S Zhang","year":"2022","unstructured":"Zhang S, Cui Y, Zhao X et al (2022) Development and validation of a prognostic nomogram for extrahepatic bile duct adenocarcinoma. Front Oncol 12:950335","journal-title":"Front Oncol"},{"key":"1856_CR25","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1080\/0284186X.2019.1590634","volume":"58","author":"M Strijker","year":"2019","unstructured":"Strijker M, Belkouz A, van der Geest LG et al (2019) Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study. Acta Oncol 58:1048\u20131055","journal-title":"Acta Oncol"},{"key":"1856_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4143\/crt.2017.595","volume":"51","author":"SY Jun","year":"2019","unstructured":"Jun SY, Sung YN, Lee JH, Park KM, Lee YJ, Hong SM (2019) Validation of the eighth american joint committee on cancer staging system for distal bile duct carcinoma. Cancer Res Treat 51:98\u2013111","journal-title":"Cancer Res Treat"},{"key":"1856_CR27","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s12029-020-00479-9","volume":"52","author":"DW Vilhordo","year":"2021","unstructured":"Vilhordo DW, Gregorio C, Valentini DF Jr, Edelweiss MIA, Uchoa DM, Osvaldt AB (2021) Prognostic factors of long-term survival following radical resection for ampullary carcinoma. J Gastrointest Cancer 52:872\u2013881","journal-title":"J Gastrointest Cancer"},{"key":"1856_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00268-020-05770-1","volume":"45","author":"S Matsui","year":"2021","unstructured":"Matsui S, Yamamoto Y, Sugiura T et al (2021) The prognostic relevance of the number and location of positive lymph nodes for ampulla of vater carcinoma. World J Surg 45:270\u2013278","journal-title":"World J Surg"},{"key":"1856_CR29","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.ejso.2017.05.024","volume":"43","author":"J Kwon","year":"2017","unstructured":"Kwon J, Kim K, Chie EK et al (2017) Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment. Eur J Surg Oncol 43:1690\u20131696","journal-title":"Eur J Surg Oncol"},{"key":"1856_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1457496916645963","volume":"106","author":"H Seppanen","year":"2017","unstructured":"Seppanen H, Juuti A, Mustonen H et al (2017) The results of pancreatic resections and long-term survival for pancreatic ductal adenocarcinoma: a single-institution experience. Scand J Surg 106:54\u201361","journal-title":"Scand J Surg"},{"key":"1856_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/MPA.0000000000000385","volume":"45","author":"MD Chandrasegaram","year":"2016","unstructured":"Chandrasegaram MD, Chen JW, Price TJ, Zalcberg J, Sjoquist K, Merrett ND (2016) Advances in molecular pathology and treatment of periampullary cancers. Pancreas 45:32\u201339","journal-title":"Pancreas"},{"key":"1856_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101414","volume":"20","author":"Z Duan","year":"2022","unstructured":"Duan Z, Zhang Y, Tang Y, Gao R, Bao J, Liang B (2022) Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: a systematic review. Transl Oncol 20:101414","journal-title":"Transl Oncol"},{"key":"1856_CR33","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11605-017-3624-6","volume":"22","author":"I Nassour","year":"2018","unstructured":"Nassour I, Hynan LS, Christie A et al (2018) Association of adjuvant therapy with improved survival in ampullary cancer: a national cohort study. J Gastrointest Surg 22:695\u2013702","journal-title":"J Gastrointest Surg"},{"key":"1856_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/bjs.10563","volume":"104","author":"A Acharya","year":"2017","unstructured":"Acharya A, Markar SR, Sodergren MH et al (2017) Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma. Br J Surg 104:814\u2013822","journal-title":"Br J Surg"},{"key":"1856_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.radonc.2009.05.006","volume":"92","author":"J Zhou","year":"2009","unstructured":"Zhou J, Hsu CC, Winter JM et al (2009) Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater. Radiother Oncol 92:244\u2013248","journal-title":"Radiother Oncol"},{"key":"1856_CR36","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s13304-023-01587-4","volume":"75","author":"N Napoli","year":"2023","unstructured":"Napoli N, Kauffmann EF, Ginesini M et al (2023) Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas. Updates Surg 75:1481\u20131496","journal-title":"Updates Surg"},{"key":"1856_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13304-023-01688-0","volume":"76","author":"M De Pastena","year":"2024","unstructured":"De Pastena M, Zingaretti CC, Paiella S et al (2024) Impact of extra-ampullary duodenal adenocarcinoma subtypes on surgical and oncological outcomes following pancreaticoduodenectomy. Updates Surg 76:87\u201395","journal-title":"Updates Surg"},{"key":"1856_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2022.101853","volume":"44","author":"M Skorzewska","year":"2022","unstructured":"Skorzewska M, Kurzawa P, Ciszewski T, Pelc Z, Polkowski WP (2022) Controversies in the diagnosis and treatment of periampullary tumours. Surg Oncol 44:101853","journal-title":"Surg Oncol"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01856-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-024-01856-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01856-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T17:05:43Z","timestamp":1728147943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-024-01856-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1007\/s13304-024-01856-w","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"type":"print","value":"2038-131X"},{"type":"electronic","value":"2038-3312"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"7 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no competing interest or funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical approval, Research involving human participants and\/or animals, and Informed consent"}}]}}